Pubblicazioni

Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients

2020 - ANNALS OF HEMATOLOGY

Scalzulli, Emilia; Colafigli, Gioia; Latagliata, Roberto; Pepe, Sara; Diverio, Daniela; Stocchi, Francesca; Di Prima, Alessio; Efficace, Fabio; Martelli, Maurizio; FoÃ , Robin; Breccia, Massimo

Proteomic analysis of quercetin-treated K562 cells

2020 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Brisdelli, F.; Di Francesco, L.; Giorgi, A.; Lizzi, A. R.; Luzi, C.; Mignogna, G.; Bozzi, A.; Schinina, M. E.

Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia

2020 - EUROPEAN JOURNAL OF HAEMATOLOGY

Cesini, L.; Frieri, C.; Barate, C.; Sora, F.; Bonifacio, M.; Cerrano, M.; Cagnetta, A.; Elena, C.; Aprile, L.; Sgherza, N.; Trawinska, M.; Gozzini, A.; Capodanno, I.; Crugnola, M.; Carmosino, I.; Scalzulli, E.; Ricci, F.; Bocchia, M.; Bergamaschi, M.; Aguzzi, C.; Sica, S.; Galimberti, S.; Breccia, M.; Luciano, L.; Latagliata, R.

How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)

2020 - CANCER MEDICINE

Breccia, Massimo; Olimpieri, PIER PAOLO; Olimpieri, Odoardo; Pane, Fabrizio; Iurlo, Alessandra; Foggi, Paolo; Cirilli, Alessia; Colatrella, Antonietta; Cuomo, Marcello; Gozzo, Lucia; Summa, Valentina; Corradini, Paolo; Russo, Pierluigi; Monitoring Registries Group, AifaâS

Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia

2020 - FRONTIERS IN ONCOLOGY

Annunziata, Mario; Bonifacio, Massimiliano; Breccia, Massimo; Castagnetti, Fausto; Gozzini, Antonella; Iurlo, Alessandra; Pregno, Patrizia; Stagno and Giorgina Specchia, Fabio

Relationship Between High Body Mass Index (BMI) and Treatment Outcomes in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Dasatinib or Imatinib: Retrospective Analysis of the Phase 3 DASISION Trial

2020 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Breccia, Massimo; Cortes Jorge, E.; Shah Neil, P.; Saglio, Giuseppe; Jimenez-Velasco, Antonio; Le Coutre, Philipp; Brun, Alexander; Degutis, Irene; Bathena, Sai; Sy, Oumar; Jabbour, Elias

Efficacy and Safety of Asciminib in Heavily Pretreated Patients with Philadelphia Chromosome-Positive (Ph plus ) Chronic Myeloid Leukemia in Chronic Phase (CML-CP) with Sensitivity to Tyrosine Kinase Inhibitors (TKIs)

2020 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Hughes, Timothy; Mauro, Michael; Kim, Dong-Wook; Cortes, Jorge; Rea, Delphine; Minami, Hironobu; Breccia, Massimo; Deangelo, Daniel; Hochhaus, Andreas; Goh, Yeow-Tee; le Coutre, Philipp; Lang, Fabian; Cacciatore, Silvia; Aimone, Paola; Stenson, Laura; Polydoros, Fotis; Talpaz, Moshe

A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation

2020 - JOURNAL OF CLINICAL MEDICINE

Dragani, Matteo; Rege Cambrin, Giovanna; Berchialla, Paola; Dogliotti, Irene; Rosti, Gianantonio; Castagnetti, Fausto; Capodanno, Isabella; Martino, Bruno; Cerrano, Marco; Ferrero, Dario; Gambacorti-Passerini, Carlo; Crugnola, Monica; Elena, Chiara; Breccia, Massimo; Iurlo, Alessandra; Cattaneo, Daniele; Galimberti, Sara; Gozzini, Antonella; Bocchia, Monica; Lunghi, Francesca; Cedrone, Michele; Sgherza, Nicola; Luciano, Luigia; Russo, Sabina; Santoro, Marco; Giai, Valentina; Caocci, Giovanni; Levato, Luciano; Abruzzese, Elisabetta; Sora, Federica; Saglio, Giuseppe; Fava, Carmen